About me
Amanda Donovan is part of Takeda’s Emerging Priorities & Innovation (EP&I) team within the R&D Global Development organization. The EP&I Team is focused on creating the next generation clinical trial, where innovation, the site, and the patient journeys converge. With 19 years of industry experience and a strong background in Global Clinical Operations and Partnership Engagement, Amanda has led multiple cross-functional teams and initiatives focused on delivering value across the R&D enterprise. Collaboration and partnership are key instruments the EP&I team use to drive success, change, and return on investment. Amanda holds a Bachelor of Science degree in Business Management from Babson College.
